Panel Discussion | Opportunities and Barriers of TMVR

Sunday, March 9, 2025

9:12 AM - 9:35 AM ET

Moderator(s)

Molly Szerlip, MD

Associate Medical Director, Education & Reserach and Regional Director, Sturctural Heart Progam
Baylor Scott and White The Heart Hospital Baylor Plano
Richardson, Texas, United States

No relationships to disclose
Dee Dee Wang, MD

Section Head Cardiac Imaging
NCH Rooney Heart Institute, Michigan, United States

No relationships to disclose
Firas Zahr, MD

Director, Interventional Cardiology
OHSU

No relationships to disclose

Panel Discussant(s)

Carlo Di Mario, MD

Professor
University of Florence
Florence, Toscana, Italy

No relationships to disclose
ME

Marvin Eng, MD

Structural Heart Disease Medical Director
Banner University Medical Center
Phoenix, Arizona, United States

Disclosure information not submitted.
Jaffar M. Khan, MD, PhD

Director of Cardiovascular Innovation and Director of Interventional Electrosurgery
St Francis Hospital and Heart Center
Roslyn, New York, United States

No relationships to disclose
Ehud Raanani, MD

Director of the Cardiothoracic and Vascular Center
Sheba Medical Center
Tel Hashomer, HaMerkaz, Israel

No relationships to disclose
Lucy Michelle Safi, DO

Assistant Professor of Medicine (Cardiology)
Mount Sinai Hospital
New York, New York, United States

No relationships to disclose
Maurice Sarano, MD

Senior Scientist
Minneapolis Heart Institute
Minneapolis, Minnesota, United States

No relationships to disclose
Ajit Yoganathan, PhD

Emeritus Regents Professor
Georgia Institute of Technology
TUCKER, Georgia, United States

Disclosure information not submitted.
Nicolas M. Van Mieghem, MD, PhD, FESC, FACC

Professor and Clinical Director of Interventional cardiology
Thoraxcenter
Rotterdam, Zuid-Holland, Netherlands

Disclosure(s): Abbott Medical NL BV: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Adjust Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Alleviant Medial Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); AncorValve: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Approxima Srl: Consulting Fees (e.g., advisory boards) (Ongoing); Bolt Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo: Consulting Fees (e.g., advisory boards) (Ongoing); Ladera: Consulting Fees (e.g., advisory boards) (Ongoing); LUMA Vision: Consulting Fees (e.g., advisory boards) (Ongoing); Materialise: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Pie Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Polares: Consulting Fees (e.g., advisory boards) (Ongoing); PulseCath BV: Consulting Fees (e.g., advisory boards) (Ongoing); Secure Closure: Consulting Fees (e.g., advisory boards) (Ongoing); Siemens: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Grant/Research Support (Ongoing); Vivasure: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Molly Szerlip, MD: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Advisory Board (Ongoing); Cardiovascular Innovations Foundation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Dee Dee Wang, MD: Abbott Vascular,: Consultant (Ongoing); Edward Lifesciences: Consultant (Ongoing); Materialise: Consultant (Ongoing)

Firas Zahr, MD: Edward Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Christian Besler, MD: Edwards, Abbott: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Carlo Di Mario, MD: BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Terminated, September 7, 2023)

Marvin Eng, MD: Edwards Lifesciences LLC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Jaffar M. Khan, MD, PhD: Abbott, Edwards Lifesciences, Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Cuspa medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Transmural Systems, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Ehud Raanani, MD: Innovalve: Co-Founder (Ongoing)

Lucy Michelle Safi, DO: Abbott Structural Heart, Medtronic, Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Maurice Sarano, MD: No financial relationships to disclose

Nicolas M. Van Mieghem, MD, PhD, FESC, FACC: Abbott Medical NL BV: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Adjust Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Alleviant Medial Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); AncorValve: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Approxima Srl: Consulting Fees (e.g., advisory boards) (Ongoing); Bolt Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo: Consulting Fees (e.g., advisory boards) (Ongoing); Ladera: Consulting Fees (e.g., advisory boards) (Ongoing); LUMA Vision: Consulting Fees (e.g., advisory boards) (Ongoing); Materialise: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Pie Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Polares: Consulting Fees (e.g., advisory boards) (Ongoing); PulseCath BV: Consulting Fees (e.g., advisory boards) (Ongoing); Secure Closure: Consulting Fees (e.g., advisory boards) (Ongoing); Siemens: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Grant/Research Support (Ongoing); Vivasure: Consulting Fees (e.g., advisory boards) (Ongoing)